TRxADE Health
(NASDAQ) MEDS
This security has been delisted. This page is retained for historical reference.
MEDS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowMEDS Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
-101%
Net Income Margin
-96%
Return on Equity
-2%
Return on Capital
-53%
Return on Assets
-49%
Earnings Yield
N/A
Dividend Yield
125.16%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$331.48M
Operating Income
$43.51B
EBITDA
$43.51B
Operating Cash Flow
$13.38B
Capital Expenditure
$0.00
Free Cash Flow
$13.38B
Cash & ST Invst.
$6.66B
Total Debt
$24.14M
TRxADE Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$431.01M
+811853.0%
Gross Profit
$330.91M
+2973543.1%
Gross Margin
76.77%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
8
N/A
Net Income
$41.50B
-565502.3%
EBITDA
$43.49B
-222217.4%
Quarterly Fundamentals
Net Cash
$6.64B
+236373.2%
Accounts Receivable
$981.33M
+23547.2%
Inventory
$213.41M
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$24.14M
+927.6%
Return on Assets
-49.31%
N/A
Return on Invested Capital
-53.42%
N/A
Free Cash Flow
$13.37B
-692746.6%
Operating Cash Flow
$13.37B
-692746.6%